The global Central Venous Catheters market Size was worth around USD 1,848.50 billion in 2021 and is estimated to grow to about USD 2607.32528 billion by 2028, with a compound annual growth rate (CAGR) of approximately 5.90 percent over the forecast period.
The global Central Venous Catheters market was worth around USD 1,848.50 billion in 2021 and is estimated to grow to about USD 2607.32528 billion by 2028, with a compound annual growth rate (CAGR) of approximately 5.90 percent over the forecast period. The report analyzes the Central Venous Catheters market’s drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the Central Venous Catheters market.
In Central Venous Catheters Market Report, Central venous catheters, also known as central lines, central catheters, or central venous access devices, play a critical role in the treatment of a wide range of medical disorders. Catheters are small, flexible tubes that are placed into a big vein near a patient's heart. The other end of the gadget makes it easier to provide medications, fluids, and other substances.
In comparison to peripheral intravenous lines, central venous catheters are longer and larger in size. People who are undergoing cancer therapy may be prescribed these devices. Patients with difficult-to-find, frail, or damaged veins, as well as those whose arms are unsuitable for intravenous line use, might consider central venous catheters. The market for Central Venous Catheters is predicted to grow as major companies develop production facilities and participate in joint ventures to manufacture these devices.
The market is being driven by rising hospitalization rates and increased catheter adoption rates. Socioeconomic factors, such as the growing geriatric population and rising incidences of various chronic diseases, including malignant cancer, are also driving the market growth. These factors are driving the demand for antimicrobial-coated catheters. The increasing number of product developments is another important growth factor.
The increased development of tip location devices that enable precise placement or positioning of the central venous catheter has fueled rapid growth in the global central venous catheter market. The reimbursement status of central venous catheters is determined by the patient's age, product category, indication, and insertion process. Manufacturers of central venous catheters are putting more money into improving product quality and design in order to reduce hazards and ensure patient safety.
During the continuing COVID-19 pandemic, the healthcare sector has encountered a number of obstacles, ranging from an increase in COVID-positive cases to increased demand for a variety of additional diagnostic options.
Furthermore, lockdown measures and transportation limitations in various countries throughout the world have had a significant influence on the healthcare sector's operations. As a result of these occurrences, a number of significant smart card manufacturers in the healthcare market have released a number of new goods and services to ensure that the healthcare system runs smoothly.
The increasing number of cardiovascular and cancer patients, the aging population, and people suffering from a variety of chronic conditions are the primary growth drivers for the Central Venous Catheters Market.
In the projected period, risks such as central vein damage, pulmonary difficulties, cardiac complications, device malfunction, catheter-related bloodstream infection, and increased usage of other vascular access devices will restrain the market.
Patients on maintenance hemodialysis still rely on central venous catheters for access. For all stakeholders involved in CVCs, there are numerous critical and developing clinical and regulatory considerations. To help promote better output results for patients getting maintenance hemodialysis, innovation, transparency, and a thorough regulatory examination of these devices are required. A committee comprised of industry leaders and members from the US Food and Drug Administration was formed to identify the primary design considerations, clinical and regulatory issues, and clinical and regulatory challenges of CVC for hemodialysis.
The global Central Venous Catheters market is segregated based on product type, Property, Design, Composition, and End-use.
Based on Property, the market is divided into Antimicrobial Catheters and Non-Antimicrobial Catheters. Antimicrobial central venous catheters account for the largest share in the market. Antimicrobial agents have been impregnated into these catheters. An antiseptic surface (silver sulfadiazine/chlorhexidine), an antibiotic coating, or a silver-impregnated collagen cuff can all be used. Antimicrobial-coated catheters have gained popularity in recent years as a result of a greater focus on preventing Healthcare-Associated Infections (HAIs), as the coated devices can provide additional protection against bloodstream infections in situations where the device is in prolonged contact with body fluids and tissue.
Based on composition, the market is segmented into Polyurethane, Polyurethane / Poly Carbonate, and Silicone Silicon catheters, which make up the majority of soft central venous catheters, and accounted for the largest share of the market growth in 2021. Silicone catheters are preferred for long-term, tunnelled CVCs due to their softness and flexibility. These, on the other hand, are sometimes utilized for temporary or short-term objectives. Silicone CVCs have a high friction coefficient.
|Historic Years||2016 - 2020|
|Forecast Years||2021 - 2028|
|Segments Covered||By Product Type, By Application, and By End Use|
|Forecast Units||Value (USD Billion), and Volume (Units)|
|Quantitative Units||Revenue in USD million/billion and CAGR from 2021 to 2028|
|Regions Covered||North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World|
|Countries Covered||U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others|
|Number of Companies Covered||10 companies with scope for including additional 15 companies upon request|
|Report Coverage||Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.|
|Customization Scope||Avail customized purchase options to meet your exact research needs.|
North America is the main market for central venous catheters, accounting for a large portion of the market's revenue growth. The reasons for this are enhanced medical facilities and well-developed healthcare infrastructure, as well as rising cancer, cardiovascular, and end-stage renal disease rates and an aging population.
Over the projection period, the market in the Asia Pacific is predicted to develop at a faster rate due to an expanding patient pool, rising government initiatives to improve healthcare facilities and rising disposable income in various countries in the area.
Some of the main competitors dominating the global Central Venous Catheters market include – Braun Melsungen AG, Becton, Dickinson and Company, ICU Medical Inc., Poly Medicure Ltd., Teleflex Incorporated Lepu Medical Technology Co., Ltd., Cook Group, Insung Medical, VOGT Medical, ZOLL Medical Corporation, EETA Surgical, QMD, Kimal and Analyst Views
Global Central Venous Catheters market is segmented as follows:
By Product Type
This report is based on in-depth qualitative and quantitative analyses of the global Central Venous Catheters market. Zion Market Research has collected and analyzed key data belong to the global Central Venous Catheters market using a variety of methods. Quantitative analysis has been done following various projection and sampling techniques.
The qualitative analysis involved primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes were validated through experts' opinions. The market dynamics have been determined after conducting a detailed study of the micro and macroeconomic indicators of the market.
Various parameters have been taken into account while estimating market size. The revenue generated by the leading industry participants in from the sales of Central Venous Catheters across the world has been calculated through primary and secondary research.
Zion Market Research employs the combination of secondary research followed by extensive primary research. Under secondary research, we refer to prominent paid as well as open access data sources including product literature, company annual reports, government publications, press releases, industry association’s magazines and other relevant sources for data collection. Other prominent secondary sources include STATISTA, trade journals, trade associations, statistical data from government websites, etc.
For this study, Zion Market Research has conducted all-encompassing primary research with key industry participants to collect first had data. Moreover, in-depth interviews with key opinion leaders also assisted in the validation of findings from secondary research and to understand key trends in the Central Venous Catheters industry. Primary research makes up the major source of data collection and validation.
We conduct primary interviews with industry participants and commentators on an ongoing basis to validate data and analysis. A typical research interview fulfills the following functions:
Participants who typically participate in such a process include, but are not limited to:
Key opinion leaders specializing in different areas corresponding to different industry verticals
Secondary research sources that are typically referred to include, but are not limited to:
News articles, press releases, and webcasts specific to companies operating in the market
Following a comprehensive secondary and primary research and insights thus gathered, analysts at Zion Research have provided an in-depth analysis of various aspects of the Central Venous Catheters market.
Where no hard data is available, we use models and estimates to produce comprehensive data sets. A rigorous methodology is adopted, wherein the available hard data is cross-referenced with the following data types to produce estimates:
The market is being driven by rising hospitalization rates and increased catheter adoption rates. Socioeconomic factors, such as the growing geriatric population and rising incidences of various chronic diseases, including malignant cancer, are also driving market growth.
According to the Market Research report, the global market was worth around USD 1,848.50 billion in 2021 and is estimated to grow to about USD 2607.32528 billion by 2028, with a compound annual growth rate (CAGR) of approximately 5.90 percent over the forecast period.
North America is the main market for central venous catheters, accounting for a large portion of the market's revenue growth. The reasons for this are enhanced medical facilities and a well-developed healthcare infrastructure, as well as rising cancer, cardiovascular, and end-stage renal disease rates and an aging population.
Some of the main competitors dominating the global Central Venous Catheters market include - Braun Melsungen AG, Becton, Dickinson and Company, ICU Medical Inc., Poly Medicure Ltd., Teleflex Incorporated, Lepu Medical Technology Co., Ltd., Cook Group, Insung Medical, VOGT Medical, ZOLL Medical Corporation, EETA Surgical, QMD, Kimal and Analyst Views